Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Neurocrine Bioscienc (NQ: NBIX)
110.05 USD  -1.43 (-1.28%)
Official Closing Price  /  Updated: 4:24 PM EDT, Oct 15, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 462,400
Open 111.08
Bid (Size) 105.00 (1)
Ask (Size) 117.00 (3)
Prev. Close 111.48
Today's Range 109.10 - 111.81
52wk Range 57.74 - 126.98
Shares Outstanding 89,897,863
Dividend Yield N/A
Performance
YTD
+38.78%
+38.78%
1 Month
-6.23%
-6.23%
3 Month
+8.59%
+8.59%
6 Month
+46.15%
+46.15%
1 Year
+80.00%
+80.00%
Top News
More News
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2018 Financial Results
Conference Call and Webcast Scheduled for Monday, November 5 Read More
from PR Newswire
New Research: Key Drivers of Growth for Neurocrine Biosciences, SS&C Technologies, Quaker Chemical, Sealed Air, KLA-Tencor, and Summit Hotel Properties — Factors of Influence, Major Initiatives and Su
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Neurocrine Biosciences,... Read More
from GlobeNewswire News Releases
More News
Read More
Neurocrine Biosciences and Jnana Therapeutics Enter Strategic Collaboration to Discover Novel Medicines to Treat Central Nervous System Disorders
from PR Newswire
Neurocrine Biosciences to Present New Long-Term Data Analyses on INGREZZA® (valbenazine) at the 2018 International Congress of Parkinson's Disease and Movement Disorders
from PR Newswire
BioTime Implements New Leadership Structure; Appoints Brian Culley as Chief Executive Officer
from Business Wire News Releases
How The Parts Add Up: PXMG Headed For $57
category ETFs
from ETF Channel
Stock Market Forecast: More Gains, More Volatility
from Investor's Business Daily
Neurocrine Biosc Up 45.8% Since SmarTrend Uptrend Call (NBIX)
from Comtex SmarTrend® News Briefs
Neurocrine Biosc Shares Up 50.6% Since SmarTrend's Buy Recommendation (NBIX)
from Comtex SmarTrend® News Briefs
Noteworthy ETF Outflows: PBE, ILMN, NBIX, NKTR
category ETFs
from ETF Channel
Here's What Could Cause Neurocrine Biosciences Shares to Skyrocket
category NBIX , Market News
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.